Evogene (EVGN) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to $0.44.
- Evogene's EPS (Basic) rose 13382.66% to $0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.44, marking a year-over-year increase of 13382.66%. This contributed to the annual value of -$2.89 for FY2024, which is 4435.57% up from last year.
- Evogene's EPS (Basic) amounted to $0.44 in Q3 2025, which was up 13382.66% from -$5794.8 recorded in Q2 2025.
- Evogene's EPS (Basic)'s 5-year high stood at $21002.4 during Q2 2022, with a 5-year trough of -$41806.7 in Q1 2023.
- In the last 5 years, Evogene's EPS (Basic) had a median value of -$3206.5 in 2024 and averaged -$8997.1.
- Over the last 5 years, Evogene's EPS (Basic) had its largest YoY gain of 20822.48% in 2022, and its largest YoY loss of 29705.52% in 2022.
- Evogene's EPS (Basic) (Quarter) stood at -$0.18 in 2021, then plummeted by 297.06% to -$0.72 in 2022, then crashed by 98.71% to -$1.44 in 2023, then skyrocketed by 105.21% to $0.07 in 2024, then skyrocketed by 493.0% to $0.44 in 2025.
- Its EPS (Basic) stands at $0.44 for Q3 2025, versus -$5794.8 for Q2 2025 and -$6807.9 for Q1 2025.